Premium
Prophylactic sclerotherapy for esophageal varices: Long‐term results of a single‐center trial
Author(s) -
Triger David R.,
Smart Howard L.,
Hosking Shorland W.,
Johnson Alan G.
Publication year - 1991
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.1840130117
Subject(s) - sclerotherapy , medicine , esophageal varices , hepatology , varices , gastroenterology , surgery , randomized controlled trial , ascites , portal venous pressure , varix , population , portal hypertension , cirrhosis , environmental health
Survival after prophylactic sclerotherapy was assessed in a single‐center study involving 99 cirrhotic (41 alcoholic) patients enrolled over 8‐yr. The wedged hepatic vein pressure gradient was measured; those with pressure ≥ 12 mm Hg were randomized to receive sclerotherapy or no treatment. The rest were not randomized. Patients in all three groups who bled were treated with emergency endoscopy and sclerotherapy. Stratification according to presence of ascites was also undertaken. Median follow‐up was 61 mo (range = 14 to 107 mo). Survival among unrandomized patients was significantly longer than among randomized patients (p < 0.006), but there was no significant difference between those treated by sclerotherapy and the controls (p = 0.27). Alcoholic cirrhotic patients undergoing sclerotherapy had better 2‐yr survival than did the controls (80% vs. 43%; p = 0.09), but this benefit was not sustained at 5 yr. Survival in the nonalcoholic patient groups was identical. Only 10 of 50 deaths were caused by variceal bleeding. Forty‐eight percent of patients with large varices bled, compared with 20% of patients with small varices. Wedged hepatic vein pressure < 12 mm Hg accurately identified alcoholic patients at low risk of variceal bleeding but not nonalcoholic patients. Only four episodes of variceal bleeding were attributable to elective sclerotherapy. We conclude that in our population, prophylactic sclerotherapy alone does not improve survival. The discrepancy in survival between alcoholic and nonalcoholic cirrhotic patients suggests that factors other than variceal hemorrhage may be responsible for the difference. (H EPATOLOGY 1991; 13:117–123).